Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin
- 1 February 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59, S53-S57
- https://doi.org/10.1046/j.1523-1755.2001.59780053.x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product bindingKidney International, 1999
- Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetesKidney International, 1998
- Advanced glycation end products modulate transcriptional regulation in mesangial cellsKidney International, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end productsKidney International, 1996
- PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end productsKidney International, 1995
- Antioxidants Reverse the Antiproliferative Effect of High Glucose and Advanced Glycosylation End Products in Cultured Rat Mesangial CellsBiochemical and Biophysical Research Communications, 1994
- Structural-functional correlations of diabetic nephropathyKidney International, 1994
- Influence of ammonia and pH on protein and amino acid metabolism in LLC-PK1 cellsKidney International, 1992
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988